U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
139594
Name Type Language
GEFURULIMAB
USAN  
Official Name English
ALXN-1720
Code English
IMMUNOGLOBULIN, BISPECIFIC, ANTI-(HUMAN SERUM ALBUMIN) (HUMAN-LAMA GLAMA MONOCLONAL ALXN1720 SINGLE-DOMAIN VHH FRAGMENT) FUSION PROTEIN WITH PEPTIDE LINKER (SYNTHETIC 15 AMINO-ACID) FUSION PROTEIN WITH ANTI-(HUMAN COMPLEMENT C5) (HUMAN-LAMA GLAMA MONOCLO
Common Name English
GEFURULIMAB [USAN]
Common Name English
gefurulimab [INN]
Common Name English
ALXN1720
Code English
Code System Code Type Description
INN
11982
Created by admin on Sat Dec 16 18:53:51 GMT 2023 , Edited by admin on Sat Dec 16 18:53:51 GMT 2023
PRIMARY
FDA UNII
6PWU78BV6C
Created by admin on Sat Dec 16 18:53:51 GMT 2023 , Edited by admin on Sat Dec 16 18:53:51 GMT 2023
PRIMARY
CAS
2456407-94-4
Created by admin on Sat Dec 16 18:53:51 GMT 2023 , Edited by admin on Sat Dec 16 18:53:51 GMT 2023
PRIMARY
USAN
JK-18
Created by admin on Sat Dec 16 18:53:51 GMT 2023 , Edited by admin on Sat Dec 16 18:53:51 GMT 2023
PRIMARY
NCI_THESAURUS
C186389
Created by admin on Sat Dec 16 18:53:51 GMT 2023 , Edited by admin on Sat Dec 16 18:53:51 GMT 2023
PRIMARY
ACTIVE MOIETY
GEFURULIMAB
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966